Troikaa Pharmaceuticals Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Troikaa Pharmaceuticals Limited Pharmaceutical Export Portfolio Dataset — 13 Products, $40.4M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Troikaa Pharmaceuticals Limited — Pharmaceutical Exporter Profile (2026) | 13 Products, $40.4M Trade | TransData Nexus

Troikaa Pharmaceuticals Limited

Indian Pharmaceutical Exporter · Analgesics & Antipyretics Specialist · $40.4M Total Trade · DGFT Verified

Troikaa Pharmaceuticals Limited is an Indian pharmaceutical exporter with a total trade value of $40.4M across 13 products in 6 therapeutic categories. Based on 1,116 verified export shipments from Indian Customs (DGFT) records, Troikaa Pharmaceuticals Limited is the #1 Indian exporter in 1 product including Fentanyl. Top exports include Diclofenac ($16.0M), Sodium ($10.2M), Heparin ($3.6M).

Troikaa Pharmaceuticals Limited — Export Portfolio & Destination Treemap

Troikaa Pharmaceuticals Limited pharmaceutical export portfolio — 13 products across 6 therapeutic categories. Source: Indian Customs (DGFT).

Who is Troikaa Pharmaceuticals Limited? — Company Overview & Market Position

Troikaa Pharmaceuticals Limited, established in 1983 by Mr. Rajni V. Patel, is a prominent Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat. The company is registered under the Corporate Identification Number (CIN) U24100GJ1994PLC022162. As of March 2026, Troikaa Pharmaceuticals is a public unlisted company, classified as a company limited by shares.

Troikaa specializes in the development and manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, with a strong emphasis on Novel Drug Delivery Systems (NDDS). The company's product portfolio spans various therapeutic categories, such as pain management, critical care, anesthesiology, and cardiology. Troikaa's innovative approach has led to the creation of path-breaking brands, with a lead time from concept to commercialization effectively maintained between 6 to 10 years.

With a workforce of over 2,800 employees, Troikaa Pharmaceuticals fosters a culture of creativity and continuous learning. The company operates three state-of-the-art manufacturing facilities in Gujarat and Uttarakhand, all certified by the World Health Organization's Good Manufacturing Practices (WHO GMP). These facilities are also approved by various regulatory agencies, including the Pharmaceutical Inspection Convention & Pharmaceutical Inspection Co-operation Scheme (PIC/S), ANVISA (Brazil), and INVIMA (Colombia).

What Does Troikaa Pharmaceuticals Limited Export? — Product Portfolio Analysis

Product Portfolio — Top 13 by Export Value

Troikaa Pharmaceuticals Limited exports 13 pharmaceutical products across 6 therapeutic categories. Market leader (#1 exporter) in 1 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Diclofenac	Analgesics & Antipyretics	$16.0M	471	4.4%	6
2	Sodium	Nutritional Supplements	$10.2M	235	2.8%	9
3	Heparin	Cardiovascular	$3.6M	72	1.0%	7
4	Enoxaparin	Cardiovascular	$2.3M	53	1.1%	8
5	Amiodarone	Cardiovascular	$1.4M	53	1.9%	6
6	Nitroglycerin	Cardiovascular	$1.3M	26	13.4%	2
7	Fentanyl	Analgesics & Antipyretics	$1.3M	48	33.6%	1
8	Zinc	Vitamins & Supplements	$1.1M	43	1.4%	15
9	Hydrocortisone	Corticosteroids	$1.0M	20	1.5%	8
10	Glucosamine	Nutritional Supplements	$946.1K	41	7.1%	5
11	Chondroitin	Nutritional Supplements	$573.8K	29	11.3%	3
12	Methylprednisolone	Corticosteroids	$458.8K	20	1.6%	10
13	Azathioprine	Immunosuppressants	$240.3K	5	0.7%	8

Troikaa Pharmaceuticals Limited exports 13 pharmaceutical products across 6 therapeutic categories with a total export value of $40.4M. The company is the #1 Indian exporter in 1 product: Fentanyl. The top category is Analgesics & Antipyretics (42.8% of portfolio), followed by Nutritional Supplements (29.1%), indicating a concentrated portfolio with the top 5 products accounting for 83.0% of total export value.

Troikaa Pharmaceuticals Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Troikaa Pharmaceuticals operates three advanced manufacturing facilities located in Gujarat and Uttarakhand, India. These facilities are equipped to produce a diverse range of pharmaceutical dosage forms, including tablets, capsules, syrups, and injections. The company's manufacturing plants are approved by the World Health Organization's Good Manufacturing Practices (WHO GMP), ensuring adherence to international quality standards. Additionally, these facilities hold certifications from the Pharmaceutical Inspection Convention & Pharmaceutical Inspection Co-operation Scheme (PIC/S), ANVISA (Brazil), and INVIMA (Colombia), reflecting their compliance with global regulatory requirements.

3Key Leadership

Troikaa Pharmaceuticals is led by a team of experienced professionals committed to the company's mission of innovation and quality. Dr. Ketan R. Patel serves as the Chairman and Managing Director, while Mr. Milan R. Patel holds the position of Joint Managing Director. Under their leadership, Troikaa has developed a strong portfolio of patented innovations and established a significant presence in the global pharmaceutical market.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Troikaa Pharmaceuticals Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Troikaa Pharmaceuticals has made significant strides in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facilities are approved by the World Health Organization's Good Manufacturing Practices (WHO GMP), and they are in the process of obtaining certifications from the European Union's Good Manufacturing Practices (EU GMP) and the U.S. Food and Drug Administration (USFDA). These certifications are crucial for market access in North America and Europe. Troikaa's products are available in over 120 countries, with a strong presence in Asia, Africa, Latin America, and the Commonwealth of Independent States (CIS).

2Emerging Markets

Troikaa Pharmaceuticals has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's adherence to international quality standards, as evidenced by certifications from WHO GMP, PIC/S, ANVISA, and INVIMA, facilitates access to these markets. Troikaa's innovative product portfolio, particularly in Novel Drug Delivery Systems (NDDS), positions it favorably in these regions, where there is a growing demand for advanced pharmaceutical solutions.

3Geographic Strategy

Troikaa Pharmaceuticals Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Troikaa Pharmaceuticals is in the process of obtaining certifications from the U.S. Food and Drug Administration (USFDA) for its manufacturing facilities. The company's plants are approved by the World Health Organization's Good Manufacturing Practices (WHO GMP) and are in the process of obtaining certifications from the European Union's Good Manufacturing Practices (EU GMP). These certifications are essential for market access in North America and Europe.

2WHO & EU GMP

Troikaa Pharmaceuticals' manufacturing facilities are approved by the World Health Organization's Good Manufacturing Practices (WHO GMP). The company is in the process of obtaining certifications from the European Union's Good Manufacturing Practices (EU GMP) and the U.S. Food and Drug Administration (USFDA). These certifications are crucial for market access in North America and Europe.

3CDSCO & Indian Regulatory

Troikaa Pharmaceuticals holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) in India. The company's facilities are approved by various regulatory agencies, including the Pharmaceutical Inspection Convention & Pharmaceutical Inspection Co-operation Scheme (PIC/S), ANVISA (Brazil), and INVIMA (Colombia). These approvals reflect Troikaa's compliance with international quality standards and regulatory requirements.

Troikaa Pharmaceuticals Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Troikaa Pharmaceuticals operates in a competitive landscape, with several key players in the pharmaceutical industry. The company's focus on Novel Drug Delivery Systems (NDDS) and its diverse product portfolio in therapeutic areas such as pain management, critical care, anesthesiology, and cardiology provide a competitive edge. Troikaa's global presence in over 120 countries and its commitment to innovation and quality further strengthen its position in the market.

2Key Differentiators

Troikaa Pharmaceuticals' key differentiators include its strong portfolio of patented innovations, particularly in Novel Drug Delivery Systems (NDDS), and its focus on difficult-to-manufacture products such as parenteral emulsions and inhalation agents for anesthesia. The company's adherence to international quality standards, as evidenced by certifications from WHO GMP, PIC/S, ANVISA, and INVIMA, further distinguishes it in the global pharmaceutical market.

3Strategic Position

Troikaa Pharmaceuticals is strategically positioned as a leader in the development and manufacturing of Novel Drug Delivery Systems (NDDS). The company's focus on innovation and quality has led to a diverse product portfolio in therapeutic areas such as pain management, critical care, anesthesiology, and cardiology. Troikaa's global presence in over 120 countries and its commitment to obtaining certifications from regulatory bodies like the USFDA and EU GMP underscore its strategic direction towards expanding its footprint in regulated markets.

Buyer Due Diligence Brief — Evaluating Troikaa Pharmaceuticals Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Troikaa Pharmaceuticals has a strong track record in manufacturing and exporting pharmaceutical products. The company's adherence to international quality standards, as evidenced by certifications from WHO GMP, PIC/S, ANVISA, and INVIMA, reflects its commitment to quality and reliability. Troikaa's diverse product portfolio and global presence in over 120 countries indicate consistent export volume and a reliable supply chain.

2Certifications to Verify

Importers should verify the following certifications when considering Troikaa Pharmaceuticals as a supplier:

WHO GMP Certification: Indicates compliance with the World Health Organization's Good Manufacturing Practices.

EU GMP Certification: Demonstrates adherence to the European Union's Good Manufacturing Practices.

USFDA Approval: Signifies compliance with the U.S. Food and Drug Administration's regulatory standards.

Frequently Asked Questions — Troikaa Pharmaceuticals Limited

How many pharmaceutical products does Troikaa Pharmaceuticals Limited export from India?

Troikaa Pharmaceuticals Limited exports 13 pharmaceutical products across 6 therapeutic categories. The top exports are Diclofenac ($16.0M), Sodium ($10.2M), Heparin ($3.6M), Enoxaparin ($2.3M), Amiodarone ($1.4M). Total export value is $40.4M.

What is Troikaa Pharmaceuticals Limited's total pharmaceutical export value?

Troikaa Pharmaceuticals Limited's total pharmaceutical export value is $40.4M, based on 1,116 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Troikaa Pharmaceuticals Limited the #1 Indian exporter?

Troikaa Pharmaceuticals Limited is the #1 Indian exporter in 1 products: Fentanyl (33.6% market share).

What therapeutic categories does Troikaa Pharmaceuticals Limited cover?

Troikaa Pharmaceuticals Limited exports across 6 therapeutic categories. The largest are Analgesics & Antipyretics (42.8%, 2 products), Nutritional Supplements (29.1%, 3 products), Cardiovascular (21.2%, 4 products).

Get Full Troikaa Pharmaceuticals Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.